↓ Skip to main content

Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)

Overview of attention for article published in BMC Cancer, October 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
2 X users
googleplus
1 Google+ user

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
44 Mendeley